ClinicalTrials.Veeva

Menu

Severity Over Time of Early Forms of Spondyloarthritis (STAR)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Not yet enrolling

Conditions

Spondyloarthritis, Axial
Spondyloarthritis

Treatments

Diagnostic Test: Diagnostic assessment

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Spondyloarthritis (SpA) is a group of chronic inflammatory pathologies whose progression over time is poorly defined, and in particular the clinical and instrumental elements that can predispose to a condition of disease severity are not completely known. It would be important to have an idea of what the predisposing factors are, possibly already at baseline, and possibly also at follow up, of severe disease, so as to be able to act early with more aggressive and targeted therapies on these patients, so as to achieve remission.

Enrollment

387 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age >18 years;
  • Diagnosis of SpA confirmed by the rheumatologist with duration of symptoms <
  • 2 years;
  • Signature of the written informed consent to the study

Exclusion criteria

  • Age < 18 years;
  • Patients suffering from other rheumatic pathologies (even in overlap), or genetic diseases such as Marfan syndrome, Ehlers Danlos syndrome
  • Any medical or psychiatric condition that in the judgment of the investigator would prevent the participant from complying with the protocol or completing the study according to the protocol.
  • Refusal to sign the informed consent to the study.

Trial contacts and locations

1

Loading...

Central trial contact

Maria Antonietta D'Agostino, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems